摘要:
The present invention provides a process for producing highly substituted purine compounds from pyrimidine compounds. Furthermore, processes of the present invention allow preparation of a library of purine compounds. Specifically the invention claims a process for the preparation of a substituted purine compound of the formula (I), wherein R1, R2, R3, R4, and R5 are as described herein.
摘要:
The present invention provides a process for producing highly substituted purine compounds from pyrimidine compounds. Furthermore, processes of the present invention allow preparation of a library of purine compounds. Specifically the invention claims a process for the preparation of a substituted purine compound of the formula (I), wherein R1, R2, R3, R4, and R5 are as described herein.
摘要:
The present invention relates to certain pyrazole derivatives of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
摘要:
The present invention relates to certain pyrazole derivatives of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
摘要:
The present invention relates to aminopyrimidine and aminopyridine derivatives having the formula (I), wherein V, X, Y, Z, R1, R4, A, B and U have the value given in the specification. The compounds are useful as an inhibitor of IkB kinases and, therefore, may be used for the treatment of inflammatory, metabolic or malignant conditions.
摘要:
The present invention relates to certain pyrazole derivatives of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.